PRECIOUS-Gold listless as investors weigh vaccine cheer against rising cases

* <?xml version="1.0" encoding="utf-16"?><root xmlns="http://CoreService.Lynx.ThomsonReuters.com/2009/03/02/Schemas "><Paragraph xml:space="preserve">Dollar falls to over 1-week low, global shares little changed Paragraph xml:space="preserve"Platinum market seen in deficit this year and next – WPIC <Paragraph xml:space="preserve">Fed’s Powell says "long way to go" for economy to recover <Paragraph xml:space="preserve">Interactive graphic tracking global spread of coronavirus: here > (Adds analyst comments, updates prices) By Asha Sistla Nov 18 (Reuters) – Gold held to a tight range on Wednesday as investors were caught between optimism over the development of novel coronavirus vaccines and the chances of more economic support as the number of infections in some places surged. Spot gold was little changed at $1,877.65 per ounce by 1026 GMT, while U.S. gold futures were down 0.5% to $1,876.60. Gold shed more than 1% on Monday after Moderna became the second U.S. drugmaker to announce late-stage successful vaccine trials. "On one side, optimism surrounding the latest vaccine developments […]

Click here to view original web page at www.reuters.com

About the author: StockMan

Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.